|
|
Article: Onychomycosis in children: an overview.
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- January 1, 2003
- Author:
CopyrightCOPYRIGHT 2003 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract
Onychomycosis in children is relatively uncommon, with a prevalence of approximately 0.3% worldwide. The most common etiologic organism is Trichophyton rubrum. The oral antifungal agents terbinafine, itraconazole, and fluconazole, and the topical nail lacquers ciclopirox and amorolfine, are not approved for use in treating onychomycosis in children. However, these agents appear to be effective and safe in this indication.
Introduction
Onychomycosis in children is relatively uncommon (Aguilar et al. 2001), with a much lower frequency in children than in adults (Gupta et al. 1997b, Gupta et al. 2000). The number of cases reported ...